nyka69 Posted June 28, 2007 Share Posted June 28, 2007 Reuters June 27, 2007 -- Abbott Laboratories said one of its experimental drugs has "huge" potential in fighting cancer by restoring the body's ability to destroy its own damaged cells. The drugmaker said that it and Genentech had agreed to develop ABT-263. The drug is designed to block a protein called Bcl-2 and restore the body's natural process of destroying its own defective or aberrant cells, controlling the growth of cancer cells. "Bcl-2 drugs could be huge, based on results we've seen in preclinical trials," said Stephen Fesik, Abbott's vice president. Fesik said early-stage human trials of the Abbott drug have focused on **small-cell lung cancer**, lymphoma and certain leukemias - areas where this type of drug will be most effective. The companies are also developing a drug, ABT-869, that chokes off the flow of nutrients to cancer cells. Quote Link to comment Share on other sites More sharing options...
P.S. I Love You Posted June 28, 2007 Share Posted June 28, 2007 That is good news. Glad you're back and hope your husband is getting through it. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You can post now and register later. If you have an account, sign in now to post with your account.